期刊文献+

粉防己碱联合谷胱甘肽对帕金森病大鼠的治疗作用 被引量:1

Therapeutical effect of Tetrandrine combined with Glutathione in rats with Parkinson's disease
下载PDF
导出
摘要 目的探讨粉防己碱(Tet)联合还原型谷胱甘肽(GSH)对帕金森病(PD)大鼠的治疗作用。方法应用定向注射6-羟基多巴胺制作PD大鼠模型;将成功模型随机分为PD组、GSH组、左旋多巴(L-dopa)组、GSH+Tet+L-dopa组、GSH+Tet组,并给予相应药物腹腔注射治疗;给药后对各组大鼠进行阿朴吗啡旋转试验、脑组织黑质谷胱甘肽、纹状体单胺氧化酶B(MAO-B)含量测定;免疫组化法观察脑组织多巴胺能神经元数目;RT-PCR技术检测酪氨酸羟化酶(TH)mRNA含量。结果(1)L-dopa组、GSH+Tet+L-dopa组、GSH+Tet组阿朴吗啡试验旋转圈数较治疗前明显减少(P<0.05~0.01);(2)GSH+Tet组脑组织GSH含量明显高于其他治疗组,MAO-B含量明显低于其他治疗组(均P<0.05);(3)GSH+Tet组脑组织TH阳性神经元数目显著多于其他各治疗组(均P<0.05);(4)GSH+Tet+L-dopa组脑组织THmRNA含量高于其他治疗组及PD组(P<0.05~0.01)。结论Tet联合GSH能增强对PD大鼠的治疗作用。 Objective To investigate the therapeutical effect of Tetrandrine (Tet) combined with Glutathione (GSH) in rats with Parkinson's disease (PD). Methods The PD model rats were established through stereotactic microinjection of 6- hydroxydopamine, then they were randomly divided into PD group, GSH group, L-dopa group, GSH + Tet + L-dopa group and GSH + Tet group. The rats were peritoneal injected with corresponding medicines. The circling behavior of rats were observed induced by Apomorphine. The levels of GSH in substantia nigra and MAO-B in striatum were assayed after treatment, the numbers of dopaminergic neuron were observed by immunohistochemistry and the contents of TH mRNA were also be assayed in each group. Results ( 1 ) Compared with pretherapy, the rotation times of groups L-dopa , GSH + Tet + L-dopa , GSH + Tet had statistical significance ( P 〈 0. 05 - 0. 01 ). (2) GSH level of GSH + Tet group was higher, MAO-B level was lower than those in other therapic groups (all P 〈0. 05 ). ( 3 ) The number of tyrosine hydroxylase positive neurone in GSH + Tet group was obviously more than that in other therapic groups (all P 〈 0. 05 ). (4)TH mRNA levels in groups PD, GSH, L-dopa and GSH + Tet + L-dopa were all lower than that in GSH + Tet group ( P 〈 0. 05 -0. 01 ). Conclusion Tet combined with GSH can enhance the therapeutical effect in PD rats.
出处 《临床神经病学杂志》 CAS 北大核心 2007年第6期444-446,共3页 Journal of Clinical Neurology
基金 江苏省卫生厅科研指导性课题(Z200518)
关键词 帕金森病 粉防己碱 还原型谷胱甘肽 Parkinson's disease Tetrandrine Glutathione
  • 相关文献

参考文献11

  • 1吴冠会,包仕尧,罗蔚峰,张志琳,霍红梅,陈应柱.依达拉奉对帕金森病大鼠多巴胺转运体保护作用的研究[J].临床神经病学杂志,2006,19(4):296-298. 被引量:10
  • 2罗蔚锋,包仕尧,刘春风,霍红梅,吴冠会,韩旺,张志琳.还原型谷胱苷肽治疗帕金森病大鼠模型的实验研究[J].临床神经病学杂志,2006,19(6):441-443. 被引量:5
  • 3Mytilineou C,Kramer BC,Yabut JA.Glutathione depletion and oxidative stress [J].Parkinsonism Relat Disord,2002,8:385.
  • 4Trevisan M,Brownie R,Ram M ,et a1.Correlates of markers of oxidative status in the general population[J]. Am J Epideraiu1, 2001,15:348.
  • 5Janaky R,Ogita K,Pasqualotto BA,et al.Glutathione and transduction in the mammalian CNS[J].J Neurochem, 1999, 73:889.
  • 6周厚广,鲍远程,陆建明,尤年兴,汪翰,杨志勇.还原型谷胱甘肽对黑质多巴胺能细胞保护作用的实验研究[J].中国神经精神疾病杂志,2004,30(3):218-220. 被引量:11
  • 7Schinkel AH.PGlycoprotein, a gatekeeper in the blood-brain barrier[J]. Adv Drug Deliv Rev,1999,36:179.
  • 8Koh SB, Ban JY, Lee BY, et al. Protective effects of fangchinoline and tetrandrine on hydrogen peroxide-induced oxidative neuronal cell damage in cultured rat cerebellar granule cells[J].Planta Med, 2003,69:506.
  • 9Dowd E, Monville C, Torres EM, et al. Lentivector-mediated delivery of GDNF protects complex motor functions relevant to human Parkinsonism in a rat lesion model[J]. Eur J Neurosci,2005,22:2587.
  • 10Ahn TB, Kim JM, Kwon KM,et al. Survival and migration of transplanted neural stem cellderived dopamine cells in the brain of parkinsonian rat[J]. Int J Neurosci,2004, 114:575.

二级参考文献34

  • 1狄晴,葛剑青,陈道文,徐肖,陈惠玲,过燕萍,李继民,石静萍,张颖冬,李作汉.依达拉奉治疗急性脑梗死的临床观察[J].临床神经病学杂志,2004,17(3):184-186. 被引量:303
  • 2秦延昆,谢海洋.依达拉奉联合降纤酶治疗急性脑梗死的疗效观察[J].临床神经病学杂志,2005,18(3):218-219. 被引量:69
  • 3包新民 舒斯之.大鼠脑立体定向图谱[M].北京:人民卫生出版社,1991.39-40.
  • 4[1]Asanuma M,Miyazaki I,Diaz-Corrales FJ,et al.Quinone formation as dopaminergic neuron-specific oxidative stress in the pathogenesis of sporadic Parkinson's disease and neurotoxin-induced parkinsonism[J].Acta Med Okayama,2004,58:221.
  • 5[2]Mercer LD,Kelly BL,Horne MK,et al.Dietary polyphenols protect dopamine neurons from oxidative insults and apoptosis:investigations in primary rat mesencephalic cultures[J].Biochem Pharmacol,2005,69:339.
  • 6[4]Larumbe IR,Ferrer Valls JV,Vines Rueda JJ,et al.Case-control study of markers of oxidative stress and metabolism of blood iron in Parkinson's disease[J].Rev Esp Salud Publica,2001,75:43.
  • 7[5]Exter DT,Sian J,Rose S,et al.Indices of oxidative stress and mitochondrial function in individuals with incidental lewy body disease[J].Ann Neurol,1994,35:38.
  • 8[6]Bharath S,Hsu M,Kaur D,et al.Glutathione,iron and Parkinson's disease[J].Biochem Pharmacol,2002,64:1037.
  • 9[7]Brown TP,Rumsby PC,Capleton AC,et al.Pesticides and Parkin-son's disease--is there a link[J]?Environ Health Perspect,2006,114:156.
  • 10[8]Mandel S,Grunblatt E,Riederer P,et al.Neuroprotective strategies in Parkinson's disease:an update on progress[J].CNS Drugs,2003,17:729.

共引文献22

同被引文献25

引证文献1

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部